 |
| 09-Oct-12 | Reiterated |
Canaccord Genuity |
Hold |
$14 → $13.50 |
|
| 25-Jun-12 | Downgrade |
Canaccord Genuity |
Buy → Hold |
$16.50 → $14.50 |
|
| 15-Jul-11 | Upgrade |
Stifel Nicolaus |
Hold → Buy |
$16.50 |
|
| 15-Jul-11 | Upgrade |
Canaccord Genuity |
Hold → Buy |
$15 → $16.50 |
|
| 14-Jun-11 | Downgrade |
Wedbush |
Neutral → Underperform |
$14 → $12 |
|
| 08-Sep-10 | Reiterated |
Wedbush |
Neutral |
$17.50 → $14 |
|
| 04-Mar-10 | Initiated |
Wedbush Morgan |
Neutral |
$17.50 |
|
| 04-Sep-09 | Reiterated |
Caris & Company |
Above Average |
$13 → $15 |
|
| 17-Jul-09 | Reiterated |
Caris & Company |
Above Average |
$15 → $13 |
|
| 07-Jan-09 | Downgrade |
Caris & Company |
Buy → Above Average |
$20 → $15 |
|
| 13-Nov-08 | Initiated |
Stifel Nicolaus |
Hold |
|
|
| 26-Sep-08 | Initiated |
Caris & Company |
Buy |
$20 |
|
| 11-Apr-08 | Reiterated |
Friedman Billings |
Mkt Perform |
$14 → $16 |
|
| 03-Apr-08 | Reiterated |
Friedman Billings |
Mkt Perform |
$16 → $14 |
|
| 07-Mar-08 | Downgrade |
Canaccord Adams |
Buy → Hold |
$25 → $16 |
|
| 13-Sep-07 | Reiterated |
Canaccord Adams |
Buy |
$23 → $25 |
|
| 23-Apr-07 | Upgrade |
Sun Trust Rbsn Humphrey |
Neutral → Buy |
$20 |
|
| 05-Apr-07 | Initiated |
Sun Trust Rbsn Humphrey |
Neutral |
|
|
| 20-Mar-07 | Initiated |
Piper Jaffray |
Market Perform |
$24 |
|
|
|
| 18-Jun-13 06:31AM | InPlay: AngioDynamics announces the FDA has granted Investigational Device Exemption approval to conduct a clinical study of the NanoKnife System for the ablation of focal prostate cancer Briefing.com |
| 06:30AM | FDA Grants Prostate IDE Approval for AngioDynamics' NanoKnife System GlobeNewswire |
| 12-Jun-13 06:30AM | Premier Selects AngioDynamics' BioFlo PICC as a Breakthrough Technology GlobeNewswire |
| 28-May-13 09:19AM | ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 07:00AM | AngioDynamics to Present at Jefferies 2013 Global Healthcare Conference GlobeNewswire |
| 21-May-13 03:32AM | ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 17-May-13 11:01AM | Taking a Closer Look at Medical Device and Product Companies, as Some are Generating High ROIs and Significant Free Cash Flow Yields Wall Street Transcript |
| 14-May-13 10:57AM | A Comprehensive Overview Of Active Electroporation Cancer Trials at Seeking Alpha |
| 07:30AM | AngioDynamics to Present at UBS Global Healthcare Conference GlobeNewswire |
| 13-Apr-13 01:04PM | ANGIODYNAMICS INC Financials EDGAR Online Financials |
| 12-Apr-13 04:37PM | Weekly Market Wrap: April 12, 2013 at Forbes |
| 08:41AM | Biolitec CEO Neuberger Ordered Arrested by U.S. Judge at Bloomberg |
| 11-Apr-13 07:58PM | Biolitec CEO Neuberger Ordered Arrested by U.S. Judge at Bloomberg |
| 01:04AM | AngioDynamics Misses on Revenues but Beats on EPS at Motley Fool |
| 10-Apr-13 12:55PM | AngioDynamics Still Struggling To Get Back On Track at Investopedia |
| 08:41AM | Company News for April 10, 2013 Zacks |
| 09-Apr-13 03:27PM | Notable companies reporting after market close theflyonthewall.com -5.19% |
| 08:51AM | Zep, AngioDynamics Announce Earnings at Forbes |
| 08:10AM | ANGO Posts Dismal 3Q Earnings Zacks |
| 08-Apr-13 11:00PM | ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online |
| 08:30PM | AngioDynamics Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 04:10PM | InPlay: AngioDynamics reports Q3 EPS above reduced expectations, rev roughly in-line; guides FY13 EPS, revs in-line Briefing.com |
| 04:01PM | AngioDynamics Reports Fiscal 2013 Third Quarter Financial Results GlobeNewswire |
| 03:24PM | Notable companies reporting after market close theflyonthewall.com |
| 11:19AM | Whisper Number Impact: Earnings Preview For AngioDynamics at Seeking Alpha |
| 07:07AM | Q3 2013 AngioDynamics Earnings Release - After Market Close CCBN |
| 06-Apr-13 08:06AM | Angiodynamics Earnings Preview: Can This Streak Continue? at Wall St. Cheat Sheet |
| 05-Apr-13 01:20PM | 5 Reasons to Worry About Next Week at Motley Fool |
| 09:01AM | Will AngioDynamics Beat These Analyst Estimates? at Motley Fool |
| 01-Apr-13 11:43AM | 3 Contenders With Novel, Non-Invasive Treatments For Cancer at Seeking Alpha |
| 28-Mar-13 04:15PM | This Hedge Fund Knows Heathcare, Do You? at Motley Fool |
| 27-Mar-13 06:30AM | AngioDynamics to Report Fiscal 2013 Third Quarter Financial Results and Hold Conference Call on April 8, 2013 GlobeNewswire |
| 18-Mar-13 03:46AM | 3 Companies Developing Novel Cancer Drug Delivery Platforms at Seeking Alpha |
| 14-Mar-13 10:42AM | Top Insider Trades: Liberty Media Increases Stake in Live Nation, and Three Major Buys at Allscripts at Minyanville |
| 08:54AM | Liberty Media Buys More Than $19 Million in Live Nation Shares and 4 Insider Trades to Note at Wall St. Cheat Sheet |
| 12-Mar-13 04:10PM | AngioDynamics Inc. Presents at Barclays Global Healthcare Conference, Mar-12-2013 01:00 PM at Seeking Alpha |
| 11-Mar-13 06:02PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:20PM | Nasdaq stocks posting largest percentage decreases AP |
| 09-Mar-13 06:00AM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 08-Mar-13 06:01PM | Nasdaq stocks posting largest percentage decreases AP -12.64% |
| 02:41PM | Why AngioDynamics Shares Tumbled at Motley Fool |
| 01:18PM | Angio Posts Dismal Prelim Results Zacks |
| 01:18PM | Nasdaq stocks posting largest percentage decreases AP |
| 12:01PM | AngioDynamics Inc., Q3 2013 Guidance/Update Call, Mar 08, 2013 at Seeking Alpha |
| 12:01PM | AngioDynamics' CEO Hosts Analyst and Investor Conference (Transcript) at Seeking Alpha |
| 06:30AM | AngioDynamics to Present at Barclays Global Healthcare Conference GlobeNewswire |
| 07-Mar-13 07:24PM | Weaker 3Q vitals "delay" growth goals at AngioDynamics at bizjournals.com |
| 05:28PM | ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online |
| 04:41PM | InPlay: AngioDynamics issues preliminary Q3 results below consensus Briefing.com |
| 04:30PM | AngioDynamics Provides Preliminary Fiscal 2013 Third Quarter Results GlobeNewswire |
| 13-Feb-13 06:30AM | AngioDynamics to Present at RBC Capital Markets Healthcare Conference GlobeNewswire |
| 04-Feb-13 09:28AM | Angio Closes Microsulis Deal Zacks |
| 01-Feb-13 06:30AM | AngioDynamics Completes Acquisition of Microsulis Medical GlobeNewswire |
| 24-Jan-13 02:28PM | ANGO and Microsulis Work Out Deal Zacks |
| 09:41AM | AngioDynamics upgraded to Buy from Neutral at Sidoti at theflyonthewall.com |
| 23-Jan-13 08:02AM | ANGIODYNAMICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 06:31AM | InPlay: AngioDynamics to acquire Microsulis' Microwave Ablation Technology for an upfront cash payment of $10.0 mln, and $5.0 mln on Dec 31, 2013; expected to be neutral to the FY13 non-GAAP EPSand accretive to FY14 Briefing.com |
| 06:30AM | AngioDynamics to Acquire Microsulis' Leading Microwave Ablation Technology GlobeNewswire |
| 22-Jan-13 11:34AM | This Metric Suggests You're Right to Own AngioDynamics. at Motley Fool |
| 17-Jan-13 02:33PM | Insiders scooping up Alcoa, Darden and others at MarketWatch |
| 02:33PM | Insiders scooping up Alcoa, Darden and others at MarketWatch |
| 15-Jan-13 09:05AM | Alcoa Director Buys 2K Shares and 3 Insider Buys to Note at Wall St. Cheat Sheet |
| 06:30AM | AngioDynamics to Host Investor and Analyst Day on January 23, 2013 GlobeNewswire |
| 13-Jan-13 03:01PM | 3 Predictions for Next Week at Motley Fool |
| 12-Jan-13 03:08PM | Celsion's Got No Reason to Be Blue at Motley Fool |
| 01:04PM | ANGIODYNAMICS INC Financials EDGAR Online Financials |
| 10-Jan-13 05:06PM | AngioDynamics Beats on EPS But GAAP Results Lag at Motley Fool |
| 09-Jan-13 02:55PM | ANGIODYNAMICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 06-Jan-13 03:01PM | 3 Predictions for Next Week at Motley Fool |
| 04-Jan-13 04:42PM | AngioDynamics Stuck In That Difficult Grey Area at Seeking Alpha |
| 08:27AM | ANGO Beats on EPS, Tweaks View Zacks |
| 03-Jan-13 08:10PM | AngioDynamics Management Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 05:27PM | ANGIODYNAMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online |
| 04:06PM | InPlay: AngioDynamics beats by $0.01, reports revs in-line; reaffirms FY13 EPS guidance, lowers FY13 revs in-line Briefing.com |
| 04:01PM | AngioDynamics Reports Fiscal 2013 Second Quarter Financial Results GlobeNewswire |
| 07:07AM | Q2 2013 AngioDynamics Earnings Release - After Market Close CCBN |
| 07:00AM | AngioDynamics to Present at the J.P. Morgan 2013 Healthcare Conference GlobeNewswire |
| 02-Jan-13 01:42PM | Whisper Number Impact: Earnings Preview For AngioDynamics at Seeking Alpha |
| 01-Jan-13 12:02PM | 3 Stories Health-Care Investors Need to Watch This Week at Motley Fool |
| 30-Dec-12 03:01PM | 3 Predictions for Next Week at Motley Fool |
| 28-Dec-12 11:26AM | 5 Reasons to Worry About Next Week at Motley Fool |
| 19-Dec-12 06:30AM | AngioDynamics to Report Fiscal 2013 Second Quarter Financial Results and Hold Conference Call on January 3, 2013 GlobeNewswire |
| 17-Dec-12 05:07PM | AngioDynamics appoints George Bourne Chief Technology & Operations Officer at theflyonthewall.com |
| 05:06PM | ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 05:02PM | InPlay: AngioDynamics appoints George Bourne Chief Technology and Operations Officer Briefing.com |
| 05:00PM | AngioDynamics Appoints George Bourne Chief Technology & Operations Officer GlobeNewswire |
| 06-Dec-12 11:39AM | CR Bard Remains Neutral Zacks |
| 21-Nov-12 01:59PM | ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 19-Nov-12 07:02PM | AngioDynamics names new CFO as Gersuk retires at bizjournals.com |
| 04:16PM | InPlay: AngioDynamics announces retirement of CFO; Mark T. Frost Appointed Chief Financial Officer Briefing.com |
| 04:08PM | Joseph Gersuk to Retire From AngioDynamics; Mark T. Frost Appointed Chief Financial Officer GlobeNewswire |
| 07:00AM | AngioDynamics to Present at the 24th Annual Piper Jaffray Healthcare Conference GlobeNewswire |
| 15-Nov-12 03:59PM | 5 Healthcare Companies With Recent Insider Buying at Seeking Alpha |
| 10-Nov-12 10:18AM | 5-Star Small Caps Set to Soar: AngioDynamics at Motley Fool |
| 06-Nov-12 12:20PM | Gibson beats Schreibmanin donations from area execs at bizjournals.com |
| 02-Nov-12 10:57AM | Wall Street Loves Celsion. Should You? at Motley Fool |
| 06:45AM | Banker sees a lot of good competition but says size, expertise put his institution out front at bizjournals.com |
| 25-Oct-12 04:06PM | ANGIODYNAMICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of S EDGAR Online |
| 17-Oct-12 04:44PM | AngioDynamics Closes Vortex Buyout Zacks |
| 02:51PM | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of New Frontier Media, Inc. (NOOF), China Shengda Packaging Group Inc. (CPGI) and AngioDynamics Inc. (ANGO) and Class Action Against OCZ Technology Group, Inc. (OCZ) PR Newswire |
|
|
| AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company operates in two segments, Vascular and Oncology/Surgery. The Vascular segment offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities; angiographic catheters and guidewires used during peripheral vascular interventional procedures; percutaneous transluminal angioplasty dilation balloon catheters; and drainage products that drain abscesses and other fluid pockets. This segment also offers thrombolytic catheters that are used to deliver thrombolytic agents; renal infusion products to deliver drugs directly to the kidneys in order to prevent and treat acute kidney injuries; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. The Oncology/Surgery segment offers radiofrequency ablation products, soft tissue surgical ablation products, microwave ablation products, surgical resection systems, and embolization products for treating benign and malignant tumors. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, and interventional and surgical oncologists directly in the United States; and directly and through distributors internationally. It has a strategic relationship with Microsulis Medical Ltd. The company was founded in 1988 and is headquartered in Latham, New York. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Greiner Charles R | VP - Global Franchise | May 09 | Sale | 10.38 | 1,495 | 15,518 | 23,221 | May 16 02:36 PM | | GOLD JEFFREY | Director | Mar 25 | Option Exercise | 6.52 | 2,508 | 16,356 | 27,741 | Mar 27 04:02 PM | | BUCCI VINCENT | Director | Mar 12 | Buy | 10.77 | 45,000 | 484,600 | 38,000 | Mar 13 03:33 PM | | BUCCI VINCENT | Director | Mar 12 | Buy | 10.78 | 40,000 | 431,200 | 78,696 | Mar 13 03:33 PM | | Meteny Dennis S | Director | Mar 12 | Buy | 10.82 | 4,600 | 49,772 | 21,950 | Mar 12 06:05 PM | | BUCCI VINCENT | Director | Feb 14 | Buy | 12.17 | 2,000 | 24,332 | 38,696 | Feb 15 06:00 PM | | Gould Kevin J | Director | Jan 11 | Buy | 11.58 | 2,700 | 31,277 | 8,250 | Jan 14 12:07 PM | | GOLD JEFFREY | Director | Nov 05 | Buy | 10.56 | 1,000 | 10,560 | 25,233 | Nov 13 10:08 AM | | Richard Stark | SVP, GM - Oncology | Nov 05 | Sale | 10.36 | 3,160 | 32,738 | 25,931 | Nov 09 12:13 PM | | DEVIVO JOSEPH | President and CEO | Jul 17 | Buy | 11.67 | 2,000 | 23,340 | 38,000 | Jul 18 02:30 PM |
|
|
|
|
|
|
